Logos Global Management LP Icosavax, Inc. Transaction History

Logos Global Management LP

  • $756 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$5.95 - $15.79 $14.7 Million - $38.9 Million
-2,465,741 Reduced 89.15%
300,000 $4.73 Million
Q3 2023

Nov 14, 2023
BUY
$7.22 - $10.05 $4.33 Million - $6.03 Million
600,000 Added 27.7%
2,765,741 $21.4 Million
Q2 2023

Aug 14, 2023
BUY
$4.89 - $10.57 $10.6 Million - $22.9 Million
2,165,741 New
2,165,741 $21.5 Million

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email